Apoptosis signal-regulating kinase-1 aggravates ROS-mediated striatal degeneration in 3-nitropropionic acid-infused mice

Biochemical and Biophysical Research Communications

Volumn 441, Issue 2, 2013, Pages 280-285

  Cho, Kyoung Joo ^a   Kim, Hyun Woo ^a   Cheon, So Yeong ^a   Lee, Jong Eun ^a   Kim, Gyung Whan ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

3 Nitropropionic acid; Apoptosis signal regulating kinase 1; siRNA; Superoxide dismutase

Indexed keywords

3 NITROPROPIONIC ACID; APOPTOSIS SIGNAL REGULATING KINASE 1; DNA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; BRAIN DISEASE; CELL DEATH; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DNA DAMAGE; ENZYME ACTIVATION; ENZYME REGULATION; FLOW CYTOMETRY; GENE SILENCING; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MALE; MITOCHONDRION; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MURINAE; MUS;

EID: 84887992967     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.08.103     Document Type: Article

References (26)

1. M.F. Beal, E. Brouillet, B.G. Jenkins, R.J. Ferrante, N.W. Kowall, J.M. Miller, E. Storey, R. Srivastava, B.R. Rosen, and B.T. Hyman Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid J. Neurosci. 13 1993 4181 4192
2. N. Bizat, J.M. Hermel, F. Boyer, C. Jacquard, C. Creminon, S. Ouary, C. Escartin, P. Hantraye, S. Kajewski, and E. Brouillet Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease J. Neurosci. 23 2003 5020 5030
3. W.T. Lee, H.S. Yin, and Y.Z. Shen The mechanisms of neuronal death produced by mitochondrial toxin 3-nitropropionic acid: the roles of N-methyl-D-aspartate glutamate receptors and mitochondrial calcium overload Neuroscience 112 2002 707 716
4. S. Almeida, A. Domingues, L. Rodrigues, C.R. Oliveira, and A.C. Rego FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures Neurobiol. Dis. 17 2004 435 444
5. S. Almeida, M. Laco, T. Cunha-Oliveira, C.R. Oliveira, and A.C. Rego BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons Neurobiol. Dis. 35 2009 448 456
6. P. Kumar, H. Kalonia, and A. Kumar Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain Drug Chem. Toxicol. 33 2010 377 392
7. G.W. Kim, and P.H. Chan Oxidative stress and neuronal DNA fragmentation mediate age-dependent vulnerability to the mitochondrial toxin, 3-nitropropionic acid, in the mouse striatum Neurobiol. Dis. 8 2001 114 126
8. J.K. Andersen Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10 Suppl 2004 S18 25
9. M.J. Hsu, C.Y. Hsu, B.C. Chen, M.C. Chen, G. Ou, and C.H. Lin Apoptosis signal-regulating kinase 1 in amyloid beta peptide-induced cerebral endothelial cell apoptosis J. Neurosci. 27 2007 5719 5729
10. H. Ichijo, E. Nishida, K. Irie, P. ten Dijke, M. Saitoh, T. Moriguchi, M. Takagi, K. Matsumoto, K. Miyazono, and Y. Gotoh Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways Science 275 1997 90 94
11. M. Saitoh, H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, M. Kawabata, K. Miyazono, and H. Ichijo Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1 EMBO J. 17 1998 2596 2606
12. K. Tobiume, A. Matsuzawa, T. Takahashi, H. Nishitoh, K. Morita, K. Takeda, O. Minowa, K. Miyazono, T. Noda, and H. Ichijo ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis EMBO Rep. 2 2001 222 228
13. L. Arning, D. Monte, W. Hansen, S. Wieczorek, P. Jagiello, D.A. Akkad, J. Andrich, P.H. Kraus, C. Saft, and J.T. Epplen ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease J. Mol. Med. 86 2008 485 490
14. Y. Sekine, K. Takeda, and H. Ichijo The ASK1-MAP kinase signaling in ER stress and neurodegenerative diseases Curr. Mol. Med. 6 2006 87 97
15. J.H. Fox, D.S. Barber, B. Singh, B. Zucker, M.K. Swindell, F. Norflus, R. Buzescu, R. Chopra, R.J. Ferrante, A. Kazantsev, and S.M. Hersch Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation J. Neurochem. 91 2004 413 422
16. K.J. Cho, B.I. Lee, S.Y. Cheon, H.W. Kim, H.J. Kim, and G.W. Kim Inhibition of apoptosis signal-regulating kinase 1 reduces endoplasmic reticulum stress and nuclear huntingtin fragments in a mouse model of Huntington disease Neuroscience 2009 1128 1134
17. G.W. Kim, and P.H. Chan Involvement of superoxide in excitotoxicity and DNA fragmentation in striatal vulnerability in mice after treatment with the mitochondrial toxin, 3-nitropropionic acid J. Cereb. Blood Flow Metab. 22 2002 798 809
18. K. Heo, Y.J. Cho, K.J. Cho, H.W. Kim, H.J. Kim, H.Y. Shin, B.I. Lee, and G.W. Kim Minocycline inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hippocampal damage after treatment with kainic acid in mice Neurosci. Lett. 398 2006 195 200
19. A. Sawa, G.W. Wiegand, J. Cooper, R.L. Margolis, A.H. Sharp, J.F. Lawler Jr., J.T. Greenamyre, S.H. Snyder, and C.A. Ross Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization Nat. Med. 5 1999 1194 1198
20. A.W. Dunah, H. Jeong, A. Griffin, Y.M. Kim, D.G. Standaert, S.M. Hersch, M.M. Mouradian, A.B. Young, N. Tanese, and D. Krainc Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease Science 296 2002 2238 2243
21. C. Bucana, I. Saiki, and R. Nayar Uptake and accumulation of the vital dye hydroethidine in neoplastic cells J. Histochem. Cytochem. 34 1986 1109 1115
22. A. Santamaria, F. Perez-Severiano, E. Rodriguez-Martinez, P.D. Maldonado, J. Pedraza-Chaverri, C. Rios, and J. Segovia Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington's disease Neurochem. Res. 26 2001 419 424
23. G.W. Kim, Y. Gasche, S. Grzeschik, J.C. Copin, C.M. Maier, and P.H. Chan Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption? J. Neurosci. 23 2003 8733 8742
24. M.T. Lin, and M.F. Beal Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 2006 787 795
25. H. Nishitoh, H. Kadowaki, A. Nagai, T. Maruyama, T. Yokota, H. Fukutomi, T. Noguchi, A. Matsuzawa, K. Takeda, and H. Ichijo ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1 Genes Dev. 22 2008 1451 1464
26. S. Bahadorani, and A.J. Hilliker Antioxidants cannot suppress the lethal phenotype of a Drosophila melanogaster model of Huntington's disease Genome 51 2008 392 395